,,ii  #aafth ,,congress  #ast ,session  
,s4 #abfh  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,may #a1 #bjai 
,ms4 ,stabenow 7for herself1 ,mr4 ,burr1
 ,mr4 ,brown1 and ,mr4 ,scott of ,south 
,carolina7 introduced the following     
bill2 which was read twice and referred 
to the ,committee on ,finance  ,a ,,bill
  ,to amend title ,,xviii of the ,social
 ,security ,act to ensure that hospitals
 receive adequate payment for the       
acquisition of hematopoietic stem cells 
under the ,medicare program1 and for    
other purposes4  #a4 ,short title ,this 
,act may be cited as the ,patient       
,access to ,cellular ,transplant ,act or
 the ,,pact ,act4  #b4 ,hematopoietic   
stem cell acquisition payments ,section 
#ahhf of the ,social ,security ,act 7#db
 ,u4,s4,c4 #acieww7 is amended--  7#a7  
in subsection 7a77#d71 in the second    
sentence1 by inserting 8for cost        
reporting periods beginning on or after 
,october #a1 #bjbj1 costs related to    
hematopoietic stem cell acquisition for 

the purpose of an allogeneic            
hematopoietic stem cell transplant 7as  
described in subsection 7d77#e77,m7710  
after 8,october #a1 #aihg7102  7#b7 in  
subsection 7d7-- 7,a7 in paragraph      
7#d77;,c77iii7--  7i7 by inserting or   
payments under paragraph 7#e77,m7       
7beginning with fiscal year #bjba7 after
 fiscal year #aiia72 and  7ii7 by       
inserting or payments under paragraph   
7#e77,m7 before the period at the end2  
and  7,b7 in paragraph 7#e71 by adding  
at the end the following new            
subparagraph3  7,m7 7i7 ,for cost       
reporting periods beginning on or after 
,october #a1 #bjbj1 in the case of a    
subsection 7d7 hospital that furnishes  
an allogeneic hematopoietic stem cell   
transplant to an individual during such 
a period1 payment to such hospital for  
hematopoietic stem cell acquisition     
shall be made on a reasonable cost      
basis4 ,the items included in such      
hematopoietic stem cell acquisition     
shall be specified by the ,secretary    

through rulemaking4  7ii7 ,for purposes 
of this subparagraph1 the term          
allogeneic hematopoietic stem cell      
transplant means1 with respect to an    
individual1 the intravenous infusion of 
hematopoietic cells derived from bone   
marrow1 peripheral blood stem cells1 or 
cord blood1 but not including embryonic 
stem cells1 of a donor to an individual 
that are or may be used to restore      
hematopoietic function in such          
individual having an inherited or       
acquired deficiency or defect4  4